These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20185196)

  • 1. Treatment of chronic hepatitis C in children: is it necessary and, if so, in whom?
    Alisi A; Comparcola D; Nobili V
    J Hepatol; 2010 Apr; 52(4):472-4. PubMed ID: 20185196
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pegylated interferon: new progress in treatment for chronic hepatitis C].
    Boyer N; Marcellin P
    Gastroenterol Clin Biol; 2000; 24(8-9):767-9. PubMed ID: 11011255
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C in hemodialysis patients.
    Casanovas T
    Hepatology; 2009 Jun; 49(6):2126; author reply 2126. PubMed ID: 19475688
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of chronic hepatitis C which failed to respond to previous treatment].
    Bronowicki JP; Nani A; Barraud H
    Gastroenterol Clin Biol; 2009 Apr; 33(4):345-52. PubMed ID: 19349132
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic hepatitis C with peginterferon alpha-2a and the factors influencing the effect of this treatment].
    Jin GD; Gong QM; Mao HJ; Xu DZ; Lu ZM
    Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):302-4. PubMed ID: 15850524
    [No Abstract]   [Full Text] [Related]  

  • 6. Peginterferon and ribavirin for hepatitis C.
    Abramowicz M
    N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
    [No Abstract]   [Full Text] [Related]  

  • 7. Conquering hepatitis C, step by step.
    Schafer DF; Sorrell MF
    N Engl J Med; 2000 Dec; 343(23):1723-4. PubMed ID: 11106723
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral effect of peginterferon alfa-2b and alfa-2a compared.
    Jansen PL; Reesink HW
    J Hepatol; 2006 Aug; 45(2):172-3. PubMed ID: 16797101
    [No Abstract]   [Full Text] [Related]  

  • 9. A success story with chronic hepatitis C.
    Weekley D; Yuen JC
    J Ark Med Soc; 2005 Dec; 102(6):158-9. PubMed ID: 16381402
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peg-interferon or pegylated interferon].
    Taeron C
    Rev Infirm; 2003 Jan; (87):51-3. PubMed ID: 12677910
    [No Abstract]   [Full Text] [Related]  

  • 11. Compare trial: updated data.
    Silva MO
    J Hepatol; 2008 Aug; 49(2):288-9. PubMed ID: 18571269
    [No Abstract]   [Full Text] [Related]  

  • 12. [PEG-interferons: significance for the treatment of viral hepatitis B and C].
    Wedemeyer H; Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S68-75. PubMed ID: 11450618
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of viral hepatitis, present and future.
    Rodés J
    J Hepatobiliary Pancreat Surg; 2003; 10(2):163-7. PubMed ID: 14505150
    [No Abstract]   [Full Text] [Related]  

  • 14. Similarities and differences between REPEAT and EPIC3.
    Poynard T; Shiff E
    Ann Intern Med; 2009 Nov; 151(10):754; author reply 754-5. PubMed ID: 19920277
    [No Abstract]   [Full Text] [Related]  

  • 15. Peginterferons in hepatitis C virus: virological, pharmacokinetic, and clinical implications. Introduction.
    Keeffe EB
    Semin Liver Dis; 2003; 23 Suppl 1():1-2. PubMed ID: 12934161
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful therapy with pegylated interferon alfa-2a. Hepatitis C patients remain virus-free].
    MMW Fortschr Med; 2003 Sep; 145(35-36):56. PubMed ID: 14584218
    [No Abstract]   [Full Text] [Related]  

  • 17. Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
    Zeuzem S
    J Hepatol; 2008 Aug; 49(2):157-9. PubMed ID: 18554745
    [No Abstract]   [Full Text] [Related]  

  • 18. PEG-IFN, RBV dosing during chronic HCV re-treatment.
    Highleyman L
    IAPAC Mon; 2007 Feb; 13(2):55. PubMed ID: 17948601
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrahepatic interferon-stimulated gene responses: can they predict treatment responses in chronic hepatitis C infection?
    Shackel NA; McCaughan GW
    Hepatology; 2007 Nov; 46(5):1326-8. PubMed ID: 17969041
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is the type of pegylated interferon important for response to treatment in patients with chronic hepatitis C infection?].
    Buti M
    Enferm Infecc Microbiol Clin; 2008 Mar; 26(3):125-6. PubMed ID: 18358209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.